COVID-19 Y SU REPERCUSIÓN EN LAS ADICCIONES
DOI:
https://doi.org/10.21134/haaj.v21i1.582Palabras clave:
adicciones, COVID-19, salud mentalResumen
Objetivo. Indagar acerca de la literatura científica emergente a nivel internacional sobre la repercusión de la pandemia por COVID-19 en las adicciones. Metodología. La base de datos Web of Science se utilizó para analizar la literatura científica sobre la pandemia por COVID-19 y la influencia que ésta pueda tener en el ámbito de las adicciones. Resultados. Se identificaron 320 documentos, de los cuales 38 cumplieron los criterios de inclusión. Sobresalieron tres problemáticas: el consumo de tabaco, opioides y alcohol. Según la literatura incipiente, entre los consumidores de opiáceos existe el riesgo de aumento de las sobredosis, así como un empeoramiento del binomio estrés-alcohol y un peor pronóstico de la enfermedad COVID-19 para los fumadores de tabaco. Destaca la preocupación por la disminución de servicios sanitarios focalizados en las adicciones y la salud mental. Conclusiones. La literatura es muy reciente y es necesaria más evidencia científica que arroje luz. Se pone de manifiesto la preocupación por el alcohol, opioides y tabaco, pero se constata la escasez de referencias a adicciones sin sustancia (nuevas tecnologías, juego online) o a los hipnóticos y las benzodiacepinas.
Descargas
Citas
Ahmed, M. Z., Ahmed, O., Aibao, Z., Hanbin, S., Siyu, L., & Ahmad, A. (2020). Epidemic of COVID-19 in China and associated Psychological Problems. Asian Journal of Psychiatry, 51, 102092. doi: 10.1016/j.ajp.2020.102092
Alexander, G. C., Stoller, K. B., Haffajee, R. L., & Saloner, B. (2020). An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Annals of Internal Medicine, 19–21. doi: 10.7326/M20-1141
Arya, S., & Gupta, R. (2020). COVID-19 outbreak: Challenges for Addiction services in India. Asian Journal of Psychiatry, 51(March), 102086. doi: 10.1016/j.ajp.2020.102086
Bansal, P., Bingemann, T. A., Greenhawt, M., Mosnaim, G., Nanda, A., Oppenheimer, J.,… Shaker, M. (2020). Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1781-1790.e3. doi: 10.1016/j.jaip.2020.04.001
Becker, W., & Fiellin, D. (2020). When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis William. Annals of Internal Medicine, 1–3. https://doi.org/10.17226/25310
Brake, S. J., Barnsley, K., Lu, W., McAlinden, K. D., Eapen, M. S., & Sohal, S. S. (2020). Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine, 9(3), 841. doi: 10.3390/jcm9030841
Comisión Interamericana para el Control del Abuso de Drogas. (2020). Covid-19 y el tratamiento de trastornos por uso de sustancias. Retrieved from http://sisco.copolad.eu/web/uploads/documentos/COVID-19_Recomendaciones_Reduccion_de_la_Demanda_Abril_30_ESP.pdf
Cai, G., Bossé, Y., Xiao, F., & Kheradmand, F. (2020). Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 201(12), 1–11. doi: 10.1164/rccm.202003-0693LE
Carrico, A. W., Horvath, K. J., Grov, C., Moskowitz, J. T., Pahwa, S., Pallikkuth, S., & Hirshfield, S. (2020). Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS and Behavior, (0123456789), 1–4. doi: 10.1007/s10461-020-02854-w
Clay, J. M., & Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health, 5(5), 30088–8. doi: 10.1016/S2468-2667(20)30088-8
da Silva, A. C. L., Martelli, H., Ferreti, P. R., Kowalskie, L. P., & da Cruz, D. E. (2020). COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling. Oral Oncology, 106. doi: 10.1016/j.oraloncology.2020.104739
Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G.,… Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(26). doi: 10.1186/s12954-020-00370-7
Editorial. (2020). The COVID-19 pandemic and mental health impacts. International Journal of Mental Health Nursing, 29, 315-318. doi: 10.1111/inm.12726
European Monitoring Centre for Drugs and Drug Addiction. (2020). EMCDDA update on the implications of COVID-19 for people who use drugs (PWUD) and drug service providers. Retrieved from https://www.emcdda.europa.eu/publications/topic-overviews/catalogue/covid-19-and-people-who-use-drugs
García, L., de la Fuente, L., Sáiz, P. A., García, M. P., & Bobes, J. (2020). ¿Se observarán cambios en el consumo de alcohol y tabaco durante el confinamiento por COVID-19? Adicciones, 32(2), 85–89. doi: 10.20882/adicciones.1546
Gurmeet, A., Mds, S., Surgery, M., & Glasgow, M. (2020). Tobacco use and vaping in the COVID-19 era. Head & Neck, 42(6), 1–3. doi: 10.1002/hed.26208
Hefler, M., & Gartner, C. E. (2020). The tobacco industry in the time of COVID-19: time to shut it down? Tobacco Control, 29(3), 245-246. doi: 10.1136/tobaccocontrol-2020-055807
Jenkins, W. D., Bolinski, R., Bresett, J., Ham, B. V., Fletcher, S., Walters, S.,… Ouellet, L. (2020). COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health, (March), 1–3. doi: 10.1111/jrh.12442
Kar, S. K., Arafat, S. M. Y., Sharma, P., Dixit, A., Marthoenis, M., & Kabir, R. (2020). COVID-19 pandemic and addiction: Current problems and future concerns. Asian Journal of Psychiatry, 51. doi: 10.1016/j.ajp.2020.102064
Kaur, J., & Rinkoo, A. V. (2020). Public health perspectives of smokeless tobacco and areca nut use in the COVID-19 era. Nicotine & Tobacco Research, xx(xx) 1–2. doi: 10.1093/ntr/ntaa081
King, D. L., Delfabbro, P. H., Billieux, J., & Potenza, M. N. (2020). Problematic online gaming and the COVID-19 pandemic. Journal of Behavioral Addictions, 9(2), 184-186. doi: 10.1556/2006.2020.00016
Lazcano, E., & Alpuche, C. (2020). Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Pública de México, 62(3), 331–340. doi: 10.21149/11408
Lee, S. A. (2020). Coronavirus anxiety scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), 393-401. doi: 10.1080/07481187.2020.1748481
Lima, N. N. R., de Souza, R. I., Gomes, P. W., de Sousa, J. L., Lima da Silva, C. G., & Neto, M. L. R. (2020). People experiencing homelessness: Their potential exposure to COVID-19. Psychiatry Research, 288, 1-2. doi: 10.1016/j.psychres.2020.112945
Lippi, G., Henry, B. M., Bovo, C., & Sanchis, F. (2020). Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis, 7(2), 85-90. doi: 10.1515/dx-2020-0041
Liu, J. J., Bao, Y., Huang, X., Shi, J., & Lu, L. (2020). Mental health considerations for children quarantined because of COVID-19. The Lancet Child & Adolescent Health, 4(5), 347-349. doi: 10.1016/s2352-4642(20)30096-1
Marsden, J., Darke, S., Hall, W., Hickman, M., Holmes, J., Humphreys, K.,… West, R. (2020). Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction, 115(6), 1007-1010. doi: 10.1111/add.15080
Olds, J. L., & Kabbani, N. (2020). Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal, 1–5. doi: 10.1111/febs.15303
Reece, A. S., & Hulse, G. (2020). America Addresses Two Epidemics – Cannabis and Coronavirus and their Interactions: An Ecological Geospatial Study. Journal: BMJ Open, 1-58. doi: 10.1101/2020.04.17.20069021
Reynolds, J., & Wilkinson, C. (2020). Accessibility of ‘essential’ alcohol in the time of COVID-19: Casting light on the blind spots of licensing? Drug and Alcohol Review, 39(4), 7–10. doi: 10.1111/dar.13076
Russo, P., Bonassi, S., Giacconi, R., Malavolta, M., Tomino, C., & Maggi, F. (2020). Early View COVID-19 and Smoking. Is Nicotine the Hidden Link? European Respiratory Journal. doi: 10.1183/13993003.01116-2020
Sani, G., Janiri, D., Di Nicola, M., Janiri, L., Ferretti, S., & Chieffo, D. (2020). Mental health during and after the COVID-19 emergency in Italy. Psychiatry and Clinical Neurosciences, 74(6), 372-373. doi: 10.1111/pcn.13004
Satre, D. D., Hirschtritt, M. E., Silverberg, M. J., & Sterling, S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, (28)7, 780-783. doi: 10.1016/j.jagp.2020.04.012
Sexton, M. (2020). Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. The Journal of Alternative and Complementary Medicine, 26(6), 444-448. doi: 10.1089/acm.2020.0144
Shalbafan, M., & Khademoreza, N. (2020). What we can learn from COVID-19 outbreak in Iran about the importance of alcohol use education. The American Journal of Drug and Alcohol Abuse, 46(3), 1–2. doi: 10.1080/00952990.2020.1753759
The tobacco Atlas. (2020). Countries. Atlanta: American Cáncer Society and Vital Strategies. Retrieved from https://tobaccoatlas.org/countries/
Tindle, H. A., Newhouse, P. A., & Freiberg, M. S. (2020). Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, xx(xx), 1–2. doi: 10.1093/ntr/ntaa077
Tsai, J., & Wilson, M. (2020). COVID-19: a potential public health problem for homeless populations. The Lancet Public Health, 5(4), e186–e187. doi: 10.1016/S2468-2667(20)30053-0
United Nations Office on Drugs and Crime. (2020). Suggestions about treatment, care and rehabilitation of people with drug use disorder in the context of the COVID-19 pandemic. Panama: UNODC. Retrieved from https://www.unodc.org/ropan/en/suggestions-about-treatment--care-and-rehabilitation-of-people-with-drug-use-disorder-in-the-context-of-the-covid-19-pandemic.html
Usher, K., Bhullar, N., & Jackson, D. (2020). Life in the pandemic: Social isolation and mental health. Journal of Clinical Nursing, 29(15-16), 2756-2757. doi: 10.1111/jocn.15290
Vázquez, J., & Redolar-Ripoll, D. (2020). COVID-19 outbreak impact in Spain: A role for tobacco smoking? Tobacco Induced Diseases, 18, 1–2. doi: 10.18332/tid/120005
Vecchio, S., Ramella, R., Drago, A., Carraro, D., Littlewood, R., & Somaini, L. (2020). COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research, 289, 113047, 1-2. doi: 10.1016/j.psychres.2020.113047
Volkow, N. D. (2020). Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine, 173(1), 61-62. doi: 10.7326/m20-1212
Wakeman, S. E., Green, T. C., & Rich, J. (n.d.). An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature Medicine, 26, 819-820. doi: 10.1038/s41591-020-0898-0
Wilson, C. G., Ramage, M., & Fagan, E. B. (2020). A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder. The Journal of Rural Health, 1-3. doi: 10.1111/jrh.12438
Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., & Xiang, Y. T. (2020). Mental health services for older adults in China during the COVID-19 outbreak. The Lancet Psychiatry, 7(4), e19. doi: 10.1016/S2215-0366(20)30079-1
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2021 Andrea Sixto Costoya, Rut Lucas Domínguez, Víctor Agulló Calatayud
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Los autores que publican en esta revista están de acuerdo con la declaración de principios éticos disponible en la web y con los siguientes términos:
Los derechos del material publicado pertenecerán a sus respectivos autores. Los artículos publicados en HAAJ se pueden utilizar bajo la licencia Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International, por lo que se permite la lectura, copia, distribución, impresión, búsqueda o realizar enlaces al texto completo de esta revista sin pedir permiso previo del editor o del autor, siempre que se referencia a HAAJ y a los autores y no se utilice con fines comerciales.
Los autores pueden incluir la obra en repositorios institucionales o en otras publicaciones siempre que se reconozca y cite adecuadamente esta revista.
El equipo editorial de HAAJ anima a los autores a difundir sus trabajos publicados a través de cualquier medio (conferencias, clases, charlas, etc.) y/o plataformas (redes sociales, repositorios, webs, etc.).
HAAJ sigue las "Core Practices" de COPE (Committee on Publication Ethics).
